Media Releases

2021

12/08/2021

Proteomics International contracts Biotem to manufacture PromarkerD test kits

11/08/2021

Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress

10/08/2021

Endometriosis Blood Test – ABC Radio

05/08/2021

Proteomics International to collaborate with University of Melbourne and Royal Women’s Hospital to develop a test for endometriosis – Proactive Investors

04/08/2021

Proteomics International to collaborate on world first blood test for endometriosis – The Sentiment

04/08/2021

Proteomics to collaborate to validate test for endometriosis

23/07/2021

6PR (Audio) – Proteomics: Predicting a disease before you get it – now that’s novel

22/07/2021

Proteomics International engages Abcam to manufacture PromarkerD reagents – Proactive Investors

22/07/2021

Proteomics engages Abcam to manufacture PromarkerD reagents

16/07/2021

Proteomics International Laboratories (ASX:PIQ) shows diabetes drug improves PromarkerD risk scores – The Market Herald

16/07/2021

Diabetes treatment lowers PromarkerD risk score: Results to be presented at Australasian Diabetes Conference

28/06/2021

Vast US market opportunity seen for Proteomics kidney test – The West Australian

28/06/2021

World-first predictive test for Diabetic Kidney Disease could save $384 billion over 10 years

10/06/2021

CCO and CFO appointed to bolster executive team

19/05/2021

Proteomics nails Avance testing contract – The West Australian

1
…
9
10
11
12
13
14
15
…
27